Abuzz Wellness Sdn Bhd

A team with 100 years experience in serving humanity globally by providing smart technology solutions in Non-invasive autopsy, digital pathology and medical sciences to overcome sickness and loss.

Our expert team of Medical Doctors, Forensic Experts, Programmers, Software QA QC have envisaged and built-in house products by Agile Scrum development methodology. We have features that solve pains of large number of affected population. Our first sale of WittyViz Digital Pathology product is done in Malaysia, and we have half a dozen inquiries. Our Diabetes Care & COVID care product & services have reached few thousands along with other medical services of our clinics. Our first version of WittyViz Forensic is ready and we have been presenting to few potential customers in Malaysia & India.

DiaCare Product:
Location: Global
Target Group: Diabetic/Pre-Diabetic, Juvenile, Gestational, Clinics, Hospitals.
Market Size: USD 33.55 Billion in Year 2026

WittyViz Digital Pathology:
Location: RCEP Countries & India
Target Group: Pathologist, Labs, Medical Universities, Veterinary Hospitals, Hospitals.
Market Size: USD 2.9 Billion in Year 2031

Forensic Imaging:
Location: RCEP Countries & India
Target Group: Hospital Forensic Department, Forensic Pathologist, Next of Kin / Family Members, Police Department, Legal Department.
Market Size: More than 70 Million Deaths in Year 2025

Pain Points for Diabetes, a Global Problem
• Undiagnosed as Diabetics/Prediabetes/Gestational due to lack of awareness
• Doctors unable to properly manage : No analytics availability

Pain Points for Digital Pathology
• Physical slides: Cannot do remote microscopy
• Loss of time to Pathologists Dr
• Stains quality decreases over time due to degeneration of dyes

Pain Points for Forensic Imaging
• Traditional methods of CSI may lead to missing out trace evidences
• Classical Autopsy procedures are time consuming
• Errors in Clinical Diagnosis

DiaCare:
• Access patients in rural, remote areas
• Disease screening, diagnosis, monitoring
• Linking of diverse medical resources
• Research, clinical trial collaborations

WittyViz Digital Pathology:
• Better outcomes
• View anywhere, anytime, support consolidated viewing
• Digital storage, Indexing, Retrieval, Training, Research, AI
• Faster, efficient, low cost
• integrated with LIS systems

Forensic Imaging:
• 3D Body viewing, virtual autopsy can perform many time
• Digital Storage, Indexing, Retrieval, Education, Research, AI
• Occupational hazard to staff handling and dissection of inf

DiaCare:
* Abbott
* Roche
* BeatO

WittyViz Digital Pathology:
* 3DHISTECH
* Omynx LLC
* Philips Healthcare

Forensic Imaging:
* No direct competitors

DiaCare:
* Comprehensive end-to-end solution which involve patients, doctors, medical centres, pharmacy, dietitians, physio centres.
* Integration solution with external medical monitoring tools.
* Tele-consultation solution.

Digital Pathology:
* A huge potential for services, teaching, education, and training
* Reduce Occupational strain of neck and to eyes of doctors
* Analysis is possible by utilizing modern technology like AI & ML on glass slide
* Expensive glass slide collections do not have to be maintained
* Original staining is preserved through digitization
* Can access the slides remotely and simultaneously

Forensic Imaging:
• 3D Body viewing, virtual autopsy can perform many times and fast.
• Digital Storage, Indexing, Retrieval, Education, Training, Research, AI
• Occupational hazard to Mortuary staff handling and dissection of infectious bodies.
• Reduce errors in Clinical Diagnosis

DiaCare Product:
* Application & Device: USD20/app
* Purchase & Support: USD25/service
* Yearly Revenue: Expected USD 9,928,000 in year-5.

WittyViz Digital Pathology:
* Product Package: USD18,750/sales
* Digital Scanning Service: USD10/scan
* Workshop: USD1,250/training
* Software: USG 75,000/Integration
* Yearly Revenue: Expected USD 35,955,000 in year-5.

Our business will be
B2C for DiaCare that will target all Diabetic patients directly.
B2B for our services that we will collaborate with Pharma makers, Logistics conpanies.

B2B for Digital Pathology solutions and B2C for services who need digitisation work.

B2B to Hospitals, Police Department and Forensic Departments for Forensic Imaging

Private Fundraising Overall Fees and Expenses 12%
DigiPath Variable Costs 12%
DigiPath Fixed Costs 9%
DigiPath Fixed Assets 3%
DiaCare Variable Costs 52%
DiaCare Fixed Costs 8%
DiaCare Fixed Assets 5%
Total 100%

Investment Amount of USD 4,500,000 for Redeemable Convertible Preference Shares,
Dividend 7% of Subscription Price per annum,
Redemption at the Subscription Price within 6 years if not already converted, Conversion rate will be 1:1.

DiaCare:
* New medication that can prevent Diabetes totally
* Diabetes patients/ sickness no longer serious /risking eyes & feet

WittyViz Digital Pathology:
* New technologies that replace.
* No longer needed Biopsy procedure

Forensic Imaging:
* Post mortem procedure is no longer needed

Global Innovation Science & Technology (GIST) Virtual Acclerator by the United States of America

Not applicable

DiaCare - Trademark No: TM2019001720
WittyViz (Digital Pathlogy) - Trademark No: TM2019001718
iCSI-DIR (WittyViz Forensic Imaging) - Trademark No: TM2019001719